Fig. 1From: The impact of reclassification of C3 predominant glomerulopathies on diagnostic accuracy, outcome and prognosis in patients with C3 glomerulonephritissection criteria of renal biopsies assessed for reclassification. C3 predominant samples were considered C3 + > 2 of magnitudes higher than any other immunereactant on IFBack to article page